$0.5085
0.01132.27%
al cierre: Nov 20, 4:00 PM EST
$0.4890
-0.0195-3.83%
After hour: 9:08 AM EST
The average analyst price target for Citius Pharmaceuticals is $65, 13192.4% above the current price. Of 4 analysts, 3 rate it Buy and 1 Hold. Targets range from $4 to $150. The latest change came on May 18, 2026, when HC Wainwright & Co. assumed coverage of Citius Pharmaceuticals with a Buy rating and a $4 price target.
Price Target Range — 10 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months
